The pharmacokinetics of eflornithine (?-difluoromethylornithine) in patients with late-stage T.b. gambiense sleeping sickness

This publication has 18 references indexed in Scilit:

• High-performance liquid chromatographic method for determination of 2-difluoromethyl-dl-ornithine in plasma and cerebrospinal fluid
  Journal of Chromatography B, 2002
• Eflornithine concentrations in serum and cerebrospinal fluid of 63 patients treated for Trypanosoma brucei gambiense sleeping sickness
  Transactions of the Royal Society of Tropical Medicine and Hygiene, 1993
• Efficacy and toxicity of eflornithine for treatment of Trypanosoma brucei gambiense sleeping sickness
  Published by Elsevier ,1992
• [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
  1989
• [Treatment of human trypanosomiasis caused by Trypanosoma brucei gambiense using alpha-difluoromethylornithine. Results in 7 patients].
  1988
• Treatment of Human Late Stage Gambiense Trypanosomiasis with α-Difluoromethylornithine (Eflornithine): Efficacy and Tolerance in 14 Cases in Côte D'Ivoire
  The American Journal of Tropical Medicine and Hygiene, 1987
• Catalytic irreversible inhibition of Trypanosoma brucei brucei ornithine decarboxylase by substrate and product analogs and their effects on murine trypanosomiasis
  Biochemical Pharmacology, 1985
• Treatment of gambiense sleeping sickness in the Sudan with oral DFMO (DL-α-difluoromethylornithine), an inhibitor of ornithine decarboxylase; first field trial
  Published by Oxford University Press (OUP) ,1985
• Polyamine metabolism and function
  American Journal of Physiology-Cell Physiology, 1982
• Further studies on difluoromethylornithine in African trypanosomes.
  1981